Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

MIRM

Mirum Pharmaceuticals (MIRM)

Mirum Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MIRM
DateTimeSourceHeadlineSymbolCompany
02/26/20253:17PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MIRMMirum Pharmaceuticals Inc
02/26/20253:09PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MIRMMirum Pharmaceuticals Inc
02/26/20253:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MIRMMirum Pharmaceuticals Inc
02/26/20253:01PMBusiness WireMirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business UpdateNASDAQ:MIRMMirum Pharmaceuticals Inc
02/24/20257:30AMBusiness WireMirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)NASDAQ:MIRMMirum Pharmaceuticals Inc
02/19/20253:04PMBusiness WireMirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025NASDAQ:MIRMMirum Pharmaceuticals Inc
02/10/20256:00PMBusiness WireMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MIRMMirum Pharmaceuticals Inc
02/04/20254:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIRMMirum Pharmaceuticals Inc
01/27/20253:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIRMMirum Pharmaceuticals Inc
01/23/20254:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIRMMirum Pharmaceuticals Inc
01/13/20257:32AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MIRMMirum Pharmaceuticals Inc
01/13/20257:30AMBusiness WireMirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate UpdatesNASDAQ:MIRMMirum Pharmaceuticals Inc
01/10/20255:30PMBusiness WireMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MIRMMirum Pharmaceuticals Inc
01/08/20253:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIRMMirum Pharmaceuticals Inc
01/06/20253:04PMBusiness WireMirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:MIRMMirum Pharmaceuticals Inc
12/10/20245:00PMBusiness WireMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MIRMMirum Pharmaceuticals Inc
11/15/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIRMMirum Pharmaceuticals Inc
11/14/20247:00AMBusiness WireMirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver MeetingNASDAQ:MIRMMirum Pharmaceuticals Inc
11/12/202410:44AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MIRMMirum Pharmaceuticals Inc
11/12/20247:14AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MIRMMirum Pharmaceuticals Inc
11/12/20247:00AMBusiness WireMirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:MIRMMirum Pharmaceuticals Inc
11/08/20245:30PMBusiness WireMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MIRMMirum Pharmaceuticals Inc
11/07/20243:30PMBusiness WireMirum Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:MIRMMirum Pharmaceuticals Inc
11/04/20243:30PMBusiness WireMirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024NASDAQ:MIRMMirum Pharmaceuticals Inc
10/31/20247:30AMBusiness WireMirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual MeetingNASDAQ:MIRMMirum Pharmaceuticals Inc
10/22/20245:06PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MIRMMirum Pharmaceuticals Inc
10/10/20246:30PMBusiness WireMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MIRMMirum Pharmaceuticals Inc
10/10/20247:30AMBusiness WireVolixibat Granted Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary CholangitisNASDAQ:MIRMMirum Pharmaceuticals Inc
09/10/20247:45PMBusiness WireMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MIRMMirum Pharmaceuticals Inc
08/28/20243:01PMBusiness WireMirum Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:MIRMMirum Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MIRM

Your Recent History

Delayed Upgrade Clock